We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microfiber Pad Helps Collect Uncontaminated Urine Samples

By LabMedica International staff writers
Posted on 27 Jan 2016
A new noninvasive microfiber pad draws urine samples in seconds, preventing cross-contamination during collection.

Developed by researchers of the BioDesign team at the Hebrew University (HUJI; Jerusalem, Israel) and Hadassah Medical Center (Jerusalem, Israel), the UCap microfiber urine collection pad contains bundles of hollow glass microfibers that quickly draw urine via capillary action from absorptive pads in just seconds. The remainder of the urine is absorbed by a polymer matrix, thus preventing cross-contamination of the urine sample by contact with the patient’s skin or fecal matter.

Image: The UCap microfiber urine collection pad (Photo courtesy of BioDesign/HUJI).
Image: The UCap microfiber urine collection pad (Photo courtesy of BioDesign/HUJI).

The low-cost but highly effective solution can save time and money in the collection of sterile samples from patients especially prone to contract a urinary tract infection (UTI), including infants and bed-ridden hospitalized patients. While sterile urine samples can be readily collected in adults using simple plastic cups, urine collections in infants and hospitalized populations relies on adhesive plastic bags or on invasive catheters.

“Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically, increasing the risk of developing antibiotic resistant bacteria,” said Amir Orlev, MD, who was part of the multidisciplinary BioDesign team set out to solve the problem under a medical innovation program.

“More than 11 million urine tests are carried out each year in infants and elderly patients. This presents a market of USD 100 million annually in the United States alone,” said BioDesign team member MBA student Itai Monnickendam. “Our low-cost urine collection pad has the potential to reduce pain and complications for millions of people and save time and expenditure for the healthcare system.”

Related Links:

Hebrew University of Jerusalem
Hadassah Medical Center



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Clinical Informatics Platform
CLARION™

Latest Clinical Chem. News

Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy
27 Jan 2016  |   Clinical Chem.

Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait
27 Jan 2016  |   Clinical Chem.

Blood Protein Panel Predicts Timing of ALS Symptom Onset
27 Jan 2016  |   Clinical Chem.



PURITAN MEDICAL